子宮内避妊器具の市場規模・シェア・成長分析 (種類別、年齢層別、地域別)：産業予測 (2024～2031年)

世界の子宮内避妊器具の市場規模は、2022年に31億2,000万米ドルと評価され、2023年の32億3,000万米ドルから2031年には43億6,000万米ドルに成長し、予測期間 (2024-2031年) のCAGRは3.8%で成長する見通しです。

子宮内避妊器具 (IUD) 市場は、計画外の妊娠、安全でない中絶の割合の増加、避妊オプションに対する意識の高まりによって大きな成長を遂げています。この需要を支えるため、政府のイニシアティブと研究開発の進歩が革新的なIUDの創出を促進しています。米国では、政府が性と生殖に関する保健サービスへのアクセス向上を推進しているため、計画的な遅発妊娠の動向がこの増加傾向を補完しています。しかし、IUDに対する認識不足、潜在的な副作用、早期抜去などの課題が、市場拡大の妨げとなっています。このような障害にもかかわらず、新興国では可処分所得の増加と健康的なライフスタイルに対する需要の高まりにより、市場関係者にとって有望な機会がもたらされています。継続的な技術革新と規制当局の支援が市場成長をさらに促進すると予想されます。

目次

イントロダクション

• 分析目的
• 市場範囲
• 定義

分析手法

• 情報調達
• 二次・一次データの手法
• 市場規模予測
• 市場の想定と制約

エグゼクティブサマリー

• 市場の概要と展望
• 需給動向の分析
• セグメント別の機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

市場の主な考察

• 主な成功要因
• 競合の程度
• 主な投資財源
• 市場エコシステム
• 市場魅力度指数 (2023年)
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術進歩
• 規制情勢
• ケーススタディ

世界の子宮内避妊器具の市場規模・CAGR：種類別 (2024～2031年)

• 非ホルモン性：銅含有IUD
• ホルモン性：プロゲストーゲン放出IUD

世界の子宮内避妊器具の市場規模・CAGR：年齢層別 (2024～2031年)

• 25～34歳
• 35～44歳
• 44歳以上
• 15～24歳

世界の子宮内避妊器具の市場規模・CAGR：流通チャネル別 (2024～2031年)

• 病院
• 婦人科クリニック
• コミュニティヘルスケアセンター
• その他

世界の子宮内避妊器具の市場規模・CAGR：エンドユーザー別 (2024～2031年)

• 病院
• クリニック
• 地域医療センター
• その他

世界の子宮内避妊器具の市場規模・CAGR (2024～2031年)

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要企業が採用した戦略
• 市場の近年の動向
• 主要企業の市場シェア（2023年）
• 主要企業のプロファイル
  • 企業概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較 (2021～2023年)

主要企業プロファイル

• AbbVie Inc.
• Bayer AG
• CooperSurgical Inc.
• DKT International
• EUROGINE, S.L.
• Mona Lisa N.V.
• OCON Medical Ltd.
• Pregna International Limited.
• Prosan International BV
• SMB Corporation of India
• Teva Pharmaceuticals
• ANI Pharmaceuticals
• Mylan NV (Viatris)
• Melbea AG
• Contrel Europe
• Durbin
• Gima S.p.A.
• HLL Lifecare Limited
• Meril Life Sciences Pvt. Ltd
• Mona Lisa N.V.

結論と推奨事項

Global Intrauterine Devices Market size was valued at USD 3.12 billion in 2022 and is poised to grow from USD 3.23 billion in 2023 to USD 4.36 billion by 2031, growing at a CAGR of 3.8% during the forecast period (2024-2031).

The intrauterine devices (IUD) market is witnessing significant growth driven by increasing rates of unplanned pregnancies, unsafe abortions, and heightened awareness of contraceptive options. To support this demand, government initiatives and advancements in research and development are fostering the creation of innovative IUDs. In the U.S., the trend towards planned delayed pregnancies complements this upward trajectory, as the government promotes better access to sexual and reproductive health services. However, challenges such as insufficient awareness of IUDs, potential side effects, and early removals hinder market expansion. Despite these obstacles, emerging economies are showing promising opportunities for market players due to rising disposable incomes and a growing demand for healthy lifestyles. Continued innovations and regulatory support are anticipated to further propel market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intrauterine Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intrauterine Devices Market Segmental Analysis

Global Intrauterine Devices Market is segmented by Type, by Age Group, by Distribution Channel, by End User and by Region. Based on Type, the market is segmented into Nonhormonal: Copper-containing IUD, Hormonal: Progestogen-releasing. Based on Age Group, the market is segmented into 25-34 years, 35-44 years, Above 44 years, 15-24 years. Based on Distribution Channel, the market is segmented into Hospital, Gynecology Clinics, Community Health Care Centers, and Others. Based on End User, the market is segmented into Hospitals, Clinics, Community Health Care Centres, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Driver of the Global Intrauterine Devices Market

The global intrauterine devices market is significantly driven by the rising awareness and acceptance of contraception. As public understanding of family planning's importance grows, so does the recognition of effective contraceptive methods, particularly long-term solutions like intrauterine devices (IUDs). This heightened awareness among individuals and healthcare professionals regarding the advantages of IUDs has led to an increased demand for these devices. Consequently, the emphasis on effective birth control options is propelling the market forward, reflecting a broader trend in society towards informed reproductive health choices and greater accessibility to reliable contraceptive methods.

Restraints in the Global Intrauterine Devices Market

The Global Intrauterine Devices market faces significant constraints due to stringent regulatory requirements. As medical devices, intrauterine devices must adhere to rigorous safety and effectiveness standards imposed by regulatory authorities. This landscape can create considerable challenges for manufacturers, making it difficult for them to meet compliance benchmarks, secure necessary approvals, and navigate the complex regulatory environment. Consequently, these stringent regulations may deter new entrants from entering the market, ultimately restricting the growth potential of the intrauterine devices sector. As a result, the combination of regulatory hurdles and compliance demands presents a notable obstacle to market expansion.

Market Trends of the Global Intrauterine Devices Market

The global Intrauterine Devices (IUDs) market is experiencing significant growth, driven by the rising incidence of unplanned pregnancies and increasing acceptance of IUDs as effective contraceptive options. Hormonal IUDs are gaining popularity, not only for their contraceptive benefits but also for their ability to manage menstrual issues, including severe cramps and heavy bleeding. Awareness initiatives by health organizations are further enhancing consumer education on family planning and the negative health impacts of unintended pregnancies. Moreover, the expanding demographic appeal of IUDs to nulliparous women and adolescents underscores a shift in contraceptive preferences, positioning the market for substantial long-term expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Intrauterine Devices Market Size by Type & CAGR (2024-2031)

• Nonhormonal: Copper-containing IUD
• Hormonal: Progestogen-releasing IUD

Global Intrauterine Devices Market Size by Age Group & CAGR (2024-2031)

• 25-34 years
• 35-44 years
• Above 44 years
• 15-24 years

Global Intrauterine Devices Market Size by Distribution Channel & CAGR (2024-2031)

• Hospital
• Gynecology Clinics
• Community Health Care Centers
• Others

Global Intrauterine Devices Market Size by End User & CAGR (2024-2031)

• Hospitals
• Clinics
• Community Health Care Centres
• Others

Global Intrauterine Devices Market Size by Region & CAGR (2024-2031)

• North America, (by Type, by Age Group, by Distribution Channel, by End User)
  • US
  • Canada
• Europe, (by Type, by Age Group, by Distribution Channel, by End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (by Type, by Age Group, by Distribution Channel, by End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (by Type, by Age Group, by Distribution Channel, by End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (by Type, by Age Group, by Distribution Channel, by End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DKT International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROGINE, S.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mona Lisa N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OCON Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Limited.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prosan International BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMB Corporation of India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANI Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan NV (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Melbea AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Contrel Europe
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Durbin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gima S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mona Lisa N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation